Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Mac the big question is why haven't the press picked up on avxl here in the usa. Australia has enough press that if released here we would be at $20 today. Who and why is this information being suppressed? Now don't say BP, they aren't the press. I think it was NBC news in Australia that did the TV story. Why isn't that released to all NBC worldwiworldwide ?
I think this is all BS. We don't need a larger study to be taken seriously. We need a partnership with big pharma for Alzheimers who will yell from the highest mountain that they have access to a monster drug with great results. Once that happens we are on the radar and we go to 30 - 50 rapidly. 1.2b mc. - 2B mc.
Then we begin P3 for Rhett, P3 for Parkinson, MS, etc. And we end the year at 60 - 80. 2.4 - 3.2 MC as word gets out that preliminary results are confirming what we already know. Then guess what. That is right, buyout at $125 or about a $6B market cap. That would be around this time next year.
Maybe the FDA doesn't have to approve. Just Australia government.
Why would you want to have a pr ah on a Friday?? Only bad news comes out then.
Biostock just an FYI I saw it as well. When I read it I thought it was a mistake. Now I am not sure.
Xena how do you know that the FDA is assisting them. I thought I remember a while back that the doctor said that they are in preparation with the FDA for a phase 3 trial. But I cannot find that anywhere. Can anybody point us to this thank you.
Xena, to me it seems that a healthy 6%-10% of shares short is quite normal for most mature stocks. When we start to jump up by $1, $5, at a time on a regular basis you can bet the shorts will not be paying 25% for my shares. They will go away until such a time as the price stabilizes. That might be at $30 pps or higher if we have the goods.
Just as an fyi and comparison, Fidelity is paying 25.25%. When these rates go to 0% we know that the shorts have backed off and we will begin to go up very rapidly. News will do this, nothing else. News of partnership, P3 for Alz kicking off, P3 for Rhett, P2 for Parkinson, etc...
You make it sound like we did something wrong in phase 2. Remember each phase is approved by the FDA. We did nothing wrong. Also remember phase 2 was designed for maximum tolerated dose and safety. Secondary was to see if the drug works this was a roaring success.
X.. OK I understand that but we are talking about over a year and we are still only at 13% institutional ownership. That is what confuses me the most. I'm starting to think that true institutional ownership will not take place for several more quarters until we get the first glimpse of what's happening in the phase 3 trial or a more significant partnership occurs.
X... could you take a minute to discuss how institutions and big pharm might be taking a position in our little avxl. I appreciate your insight but I don't understand how and why this little accumulation dance really occurs. It seems like this has been going on for over a year without any price or insty increase. Why aren't we at $10 per share already? 15? 20? Why don't we have at least 50% insty ownership already? Anyone who wants to buy this stock could have over the last year at great prices. Please help me as I just don't get it . I am very long for the past 2 years with over 30k shares and my patience remains strong as long as the news continues to be good.. just looking for the big picture strategy. Thanks
I just picked up 10 contracts for the January 2019 2.50 strike for only $2.50. What is wrong with that picture. There is no premium in this at all and I expected it to be a $100 stock by then. We get no love for this stock. Only.75c and I get 2 years for this to cook.
I don't think there is any short cover going on. If there was they would not be paying me 24%still
I don't believe anyone will have the data until tomorrow. This is SEC rules not conf rules. These guys could be trading on this info after hours. Abstracts will not be released until tomorrow.
Shorts not covering yet still paying 24% from Fidelity
That can't be as Fidelity is paying me currently 24%
Yes i agree, but if you are going to own the stock and you can't beat them,join them. I always worry that the shorts are right and they have power.
24% on the $ value of my shares per year and distributed monthly. I have 30k shares x $4. That is 120k getting 24% for as long as they want to pay me. My hope is that come Dec 12 they pay me nothing and the stock is at $30.
Can someone please explain to me how the DRYS call options work. On the dec 16th option chain it says the following:
Adjusted: 1 Drys, $2.64 cash, 100 multiplier
Not sure what that means. I went and bought 25 of the Dec 16, $5 strikes for 2 cents. Just playing a lottery ticket. But the stock has moved a $1 and the options have not moved.
Thanks in advance.
Just an fyi as someone asked before. Fidelity is paying me 24% to borrow my shares. I hope the shorts are wrong but they are not done trying to drive this price down. With AF coming out again today bashing avxl, the powers that be still want to harm us.
https://www.thestreet.com/story/13908604/3/biotech-stock-mailbag-looking-for-an-investable-idea-in-alzheimer-s-mine-field.html
We do not have to dilute (too much ). BIIB can buy shares at say $15pps for 5M new shares plus revenue sharing. BIIB handles all the development, manufacturing, etc and we get to share the rev. Maybe we get a deal worth high teens % on sales. Is that dilution?? I think not that bad. That gives us $75M and we now have a new level for our stock. That is for one indication, MS. We now will trade on the science so if we can get a deal like that add in the great news for alz, Parkinson's, Retts, etc we can get to a $50pps and a $2B market cap pretty quickly. Add in a partnership for Alz and Parkinson we are at $100 or a $4.5B market cap. Very realistic. Only one thing stopping us, does the drug work??
Big 76,000 sell order in at 4.20. It looks like someone is trying to hold us down
15 for 1 reverse split just announced. Maybe the next step is a move to Nasdaq. Typically this is a kiss of death just to stay listed but I remember Hassett once told me that they will be doing this to get onto the nas. I just thought it would have been a year ago. Maybe, just maybe they have their act together.
Good news on patent today. Nice little uptick. Better news last week with Ted leaving. Maybe we can get back to. .50c over the next couple of months.
Hey Turk. Hope all is well. I follow on twitter but do not post. How did you make your way to warm? You still in mslp.
Xena, IR most certainly did tell me that. He did not want me to get to excited buy that purchase by Vanguard. He told me point blank that it was an index fund purchase by vanguard which correlates with the timing of the buy. Now I really don't care if it is index fund because they become long term holders. To me it kind of makes sense that it is an index purchase. If they did their research and made such a large buy on such a small company they would probably put out a research report. But since it could be an index buy, then no research.
BTW, I am a very long term holder of admp. I hope I will not be labeled a dreaded short because of me relaying this info. Someone else should call IR to confirm this as well. I think it was a guy from the new firm in Canada that is handling the IR. I could be wrong as this was a few months ago.
Xena, we also traded some emails a while back showing my strong long position.
Sorry if I got anyone's goat with this comment.
I believe that vanguard has to buy for there index positions. It is not like they are in love with avxl. That is what IR told me. I like it
Hey Kayak. Just wondering what your take on todays PR and move forward. They also released a withdrawal on their S1 from a long time ago. Stock moved about .05c early on but only up .02c now.
Two news and we go over 10??
Gemmini Master Partnership is now a 9.9% holder of shares or 12.3%.
http://archive.fast-edgar.com//20161011/A222V22CLC2272BZ282F2WX26GIAM222Z282/
So is this run from Friday for real or just another pump and dump?
Shorts are done for now. Fidelity is not looking for shares to borrow. We go up.
Xena time will tell. The people who need to understand do. The cable doesn't care what the data means. They will short and destroy all the time
Does this ring a bell to anyone here??
https://www.thestreet.com/story/12725934/1/the-seven-deadly-sins-of-biotech-investing.html
Big roadblock being put up early at $7.60. 34,000 shares on the ask.
Some big blocks on the ask are trying to keep us under 7.52. Let's see one of the big institutions take these out by the end of the day
Yes but 75 comes before 125 and 75 comes on partnership. Within 6 months.
We certainly are not acting like a stock that is about to release great information on Sunday
Does anyone know if Sunday or Wednesday is the more important day for data? Thx